Thomasius, Friederike
Palacios, Santiago
Alam, Asif
Boolell, Mitra
Vekeman, Francis
Gauthier, Geneviève
Funding for this research was provided by:
Theramex
Article History
Received: 5 April 2021
Accepted: 17 August 2021
First Online: 6 September 2021
Declarations
:
: Not applicable. Data are de-identified and comply with the Health Insurance Portability and Accountability Act (HIPAA) of 1996. Accordingly, this study did not require approval from an institutional review board or collection of inform consent.
: Not applicable.
: Not applicable.
: FT has received fees for lectures and consultancy or investigator fees from Amgen, Gedeon Richter, Lilly, Hexal, Kyowa Kirin, Hologic, Novartis, Stada, Synexus, Theramex, and UCB. SP is a consultant for Pfizer, Amgen, MSD, Procare, Health, Bayer, Besins, Sérélys Shinogi, Exeltis, Gedeon Richter, Theramex, and UCB. AA and MB are employees of Theramex. FV and GG are employees of STATLOG, Inc., which has received research funding from Theramex for this study.